Pharma & Biotech

The weight-loss pharmaceutical sector experienced significant turbulence following a social media post from former President Donald Trump. His call for...

A dramatic financial showdown is unfolding around Intellia Therapeutics, where extreme market pessimism collides with groundbreaking medical innovation. The biotech...

Johnson & Johnson is undertaking a profound strategic shift, moving away from its established business model through a significant divestment....

NuCana plc witnessed dramatic trading activity on Wednesday, with its shares swinging by more than 15% before ultimately closing nearly...

Pharmaceutical giant Bristol-Myers Squibb faces a critical transition period as it races to offset substantial revenue declines expected from key...

Shares of Viking Therapeutics are experiencing significant price swings as investors position themselves ahead of the company's October 22 quarterly...

Investors in pharmaceutical leader AbbVie are navigating a period of significant uncertainty as the company approaches its third-quarter earnings release....

Assembly Biosciences is experiencing a substantial equity rally, fueled by encouraging clinical trial outcomes and reinforced confidence from financial analysts....

As markets await forthcoming quarterly results, BioNTech is signaling its strategic direction beyond the pandemic era. The German biopharmaceutical company...

The biotechnology firm aTyr Pharma faces an unprecedented crisis as its stock value collapses and legal challenges mount. This dramatic...